Answer
Yes. The selected products include paediatric use for congenital deficiency, but laboratory recovery and clearance may differ in younger or smaller children, requiring specialist individualisation.
Sources for this answer
- FIBRYGA 1g powder and solvent for injection / infusion — Current selected SmPCemc · Summary of Product Characteristics
- Riastap 1g — Current selected SmPCemc · Summary of Product Characteristics